StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > How is this 18 Cents Under the last PP

<< Previous

Bullboard Posts

Next >>

Comment by skiboard09on Dec 21, 2020 6:10pm

137 Views

Post# 32157919

RE:RE:How is this 18 Cents Under the last PP

With more and more lockdowns and less people get screened for cancer you'd think Aristotle could be huge in a big way. Can get blood taken from your house and find out if you have any of the 10 cancers. I'm trying to figure out why we keep dropping. Financing closed over 20% higher. Increasing revenue from testing. Adding clients. Is it previous over promising of Mr Tripp and market won't acknowledge what we have here till he delivers Aristotle to market?

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario